Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Octaplas in Pediatric Therapeutic Plasma Exchange
NCT01938378Phase 4Completed
- Sponsor
- Octapharma
- Start
- Apr 2015
- Primary completion
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes, Tissue Cells
- Countries
- 1
01
Overview
A Phase 4 trial of octaplas lg, sponsored by Octapharma. Started Apr 2015; status: completed.
02
Drugs
octaplas lg
Beyond the preview
Go deeper on NCT01938378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01938378.